ZFP36L1 and neuroendocrine neoplasm: ZFP36L1 is likewise expressed at low levels in other ASCL1-positive neuroendocrine tumors including neuroblastoma, that like SCLC, are dependent on ASCL130, suggesting that low ZFP36L1 expression is a common feature across high-grade neuroendocrine tumors.